Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Cancer Medicine|July 10, 2019
Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remissionPierre-Yves Dumas, Emilie Bérard, Claire Bréal, et al.
The Journal of Pathology|May 13, 2015
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemiaRomain Gioia, Claire Trégoat, Pierre-Yves Dumas, et al.
Oncotarget|December 13, 2017
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescenceAngela Ianniciello, Pierre-Yves Dumas, Claire Drullion, et al.
BMC Cancer|November 14, 2018
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasmsPierre-Yves Dumas, Olivier Mansier, Valerie Prouzet-Mauleon, et al.
Blood Advances|September 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO studyRaynier Devillier, Edouard Forcade, Alice Garnier, et al.
Cancer|December 2, 2016
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Norbert-Claude Gorin, Myriam Labopin, Tomasz Czerw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2015
Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated DonorsClaire Calmettes, Stéphane Vigouroux, Myriam Labopin, et al.
Oncotarget|June 22, 2018
Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxisClaire Calmettes, Frederic Gabriel, Elodie Blanchard, et al.
Leukemia Research|January 12, 2024
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry studyIbrahim Didi, Jean-Marc Alliot, Pierre-Yves Dumas, et al.
Leukemia & Lymphoma|May 31, 2022
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry studyNoémie Gadaud, Harmony Leroy, Emilie Bérard, et al.
Pageof 7